Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,600.00    -50.00 (-0.88%)
Bid:
5,550.00
Ask:
5,650.00
Spread: 100.00 (1.802%)
Market Cap: £141.56m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Directorate Change

22 Dec 2017 09:42

RNS Number : 2048A
Camellia PLC
22 December 2017
ย 

22 December 2017

ย 

Camellia Plc

(the "Company")

ย 

Board Appointment

Camellia Plc is pleased to announce the appointment of Gautam Dalal as a non-executive director with effect from 1 March 2018.

Mr Dalal, FCA, FRSA, aged 62, is a chartered accountant. He was a partner of KPMG London from 1990 to 2010. During this period, he helped establish KPMG's practice in India and was its Chairman and CEO from 2000 to 2003, based in Mumbai. On his return to the UK, he was Founder-Director of the UK India Business Council and a member of the Asian Business Association. Mr Dalal is a Non-Executive Director and Vice Chair of the Barts Health NHS Trust and a Non-Executive Director of ZincOx Resources plc. He is also a Trustee and Treasurer of SOAS, University of London. He has been a Trustee of The National Gallery and a Director of AMREF Health Africa's International Board, an NGO headquartered in Nairobi.

Further information, as required pursuant to Schedule 2(g) of the AIM Rules for Companies, is set out below:-

Current directorships/partnerships

ย 

ZincOx Resources plc - Non-executive Director and Chair of the Audit Committee

Barts Health NHS Trust - Non-executive Director and Vice Chair

SOAS, University of London - Trustee and Treasurer

ย 

Past directorships/partnerships within the last 5 years

ย 

The Law Society - Chair of the Audit Committee

The National Gallery - Trustee and Chair of the Audit and Finance Committees

AMREF Health Africa UK - Trustee, Treasurer and Chair from February 2011

AMREF Health Africa International - Director

There are no further disclosures required under Schedule 2(g) of the AIM Rules for Companies.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

ย 

Enquiries

Camellia Plc

01622 746655

Malcolm Perkins, Chairman

Tom Franks, CEO

Susan Walker, CFO

ย 

Panmure Gordon

0207 886 2500

Nominated Advisor and Broker

Andrew Godber

Erik Anderson

ย 

This information is provided by RNS
The company news service from the London Stock Exchange
ย 
END
ย 
ย 
BOATTBLTMBJTMLR
Date   Source Headline
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20258:29 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTrading Update
27th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSDisposal
5th Dec 20247:00 amRNSDisposal
11th Nov 20248:06 amRNSSale of Bangladesh associate companies
31st Oct 202411:37 amRNSDisposal
25th Oct 202412:51 pmRNSHolding(s) in Company
17th Oct 20247:00 amRNSTrading Statement
6th Sep 202411:44 amRNSInterim Report 2024
6th Sep 20247:00 amRNSHalf-year Report
1st Jul 20247:00 amRNSDirector Changes
28th Jun 20241:00 pmRNSUpdate on BF&M Transaction
7th Jun 202411:14 amRNSResult of AGM
6th Jun 20247:00 amRNSTrading Update
1st May 202412:30 pmRNSAnnual Report & Notice of Annual General Meeting
29th Apr 20247:00 amRNSFinal Results
25th Apr 20247:00 amRNSDirector Changes
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.